drugset / Trial / NCT03020719

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

NCT03020719

RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.

Timeline

Start
2017-06-14
Primary completion
2018-12-12
Completion
2018-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutathione Peptide 65 mg/kg Oral

Indications